A new simple and rapid validated RP-HPLC method for determination of ziprasidone in ziprasidone capsules by Ruchi Bansal, Karthikeyan Chandrabose, N.S. Hari Narayana Moorthy, Dhirendra Pratap Singh, Digvijay Singh, Piyush Trivedi

Subjects: Get full text

Significance of Ziprasidone Nanoparticles in Psychotic Disorders by Mamta Patil, Javesh Patil, Devyani Patil, Kiran Patel, Aayushi Tatiya

Subjects: “…ziprasidone…”
Get full text

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill by Seema M. Patel, PharmD, BCPP, Ericka L. Crouse, PharmD, BCPP, BCGP, FASHP, FASCP, James L. Levenson, MD

Subjects: Get full text

Ziprasidone-induced stuttering： a case report by Sun Zhenxiao, Liu Huaxue

Subjects: “…ziprasidone…”
Get full text

Drug eruption caused by ziprasidone： a case report by Hong Jiakun, Sun Yanbing, Liu Xiaobing

Subjects: “…ziprasidone…”
Get full text

Human Hemoglobin and Antipsychotics Clozapine, Ziprasidone and Sertindole: Friends or Foes? by Lena Platanić Arizanović, Nikola Gligorijević, Ilija Cvijetić, Aleksandar Mijatović, Maja Krstić Ristivojević, Simeon Minić, Aleksandra Nikolić Kokić, Čedo Miljević, Milan Nikolić

Subjects: Get full text

Efficacy and Tolerability of Ziprasidone Use in Children and Adolescents, a Systemic Review and Meta Analysis by A. Wadhwa, A. Sareen, C. Soeung, I. Penuelas-Calvo

Subjects: “…Ziprasidone…”
Get full text

Atypical Antipsychotic Drug Ziprasidone Protects against Rotenone-Induced Neurotoxicity: An In Vitro Study by Kazuki Terada, Ayumi Murata, Erina Toki, Shotaro Goto, Hirofumi Yamakawa, Shuichi Setoguchi, Daisuke Watase, Mitsuhisa Koga, Jiro Takata, Kazuhisa Matsunaga, Yoshiharu Karube

Subjects: Get full text

Acne caused by ziprasidone in a young patient with bipolar disorder: A case report by Yiwen Yuan, Yiwen Yuan, Xiaoqing Li, Xiaoqing Li, Xingmei Jiang, Xingmei Jiang, Zhixiong Li, Ying Ou, Ying Ou, Zhe Li, Zhe Li

Subjects: “…ziprasidone…”
Get full text

Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone by Svein Isungset Støve, Åge Aleksander Skjevik, Knut Teigen, Aurora Martinez

“…Several existing β2-adrenergic agonists and antagonists, as well as the atypical antipsychotic ziprasidone, are identified as high affinity VMAT2 inhibitors, which could have implications for drug repurposing and drug derivatization campaigns.…”
Get full text

Tolerability of Ziprasidone Use in Children and Adolescents: A Prisma Model: Systematic Review and Meta-Analysis by J. Jay, A. Sareen, N. Hassan, N. Dumlao, K. Jose, I. Haza, A. Wadhwa, S. Gunturu

Subjects: Get full text

Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid–Polymer Hybrid Nanocarriers by Hadel A. Abo El-Enin, Alaa S. Tulbah, Hany W. Darwish, Rania Salama, Ibrahim A. Naguib, Heba A. Yassin, Hend Mohamed Abdel-Bar

Subjects: Get full text

Ziprasidone Induces Rabbit Atrium Arrhythmogenesis via Modification of Oxidative Stress and Sodium/Calcium Homeostasis by Buh-Yuan Tai, Ming-Kun Lu, Hsiang-Yu Yang, Chien-Sung Tsai, Chih-Yuan Lin

“…KN-93 suppressed the enhanced late Na⁺ current in ziprasidone-treated atrial myocytes. Atrial myocytes treated with ziprasidone showed reduced Ca²⁺ transient amplitudes and sarcoplasmic reticulum (SR) Ca²⁺ stores, and increased SR Ca²⁺ leakage. …”
Get full text

In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma by Ankita Sahu, Shaban Ahmad, Khalid Imtiyaz, Ajeeshkumar Kizhakkeppurath Kumaran, Mojahidul Islam, Khalid Raza, Murugesh Easwaran, Asha Kurukkan Kunnath, Moshahid A. Rizvi, Saurabh Verma

“…We conclude that the compound ziprasidone effectively blocks the cell cycle at the G1-S phase and induces cancer cell death. …”
Get full text

Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination by Milena Rmandić, Đorđe Vasilić, Marija Rašević, Mira Zečević, Biljana Otašević, Ana Protić, Anđelija Malenović

Subjects: Get full text

Olanzapine, risperidone and ziprasidone differently affect lysosomal function and autophagy, reflecting their different metabolic risk in patients by Marco Pozzi, Chiara Vantaggiato, Francesca Brivio, Genny Orso, Maria Teresa Bassi

“…We thus assessed, in clinically-relevant culture conditions, the aetiopathogenic mechanisms of olanzapine, risperidone and ziprasidone, antipsychotics with respectively high, medium, low metabolic risk in patients, finding relevant differences among them. …”
Get full text

Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course by L. A. Ivanova, O. P. Vorsina, T. A. Eliseeva, K. A. Frolovа, E. V. Sapozhnikova

Subjects: Get full text

Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia by Jan P. A. M. Bogers, Jasper A. Blömer, Lieuwe de Haan

Subjects: Get full text

Use of a New Ziprasidone-Selective Electrode in Mixed Solvents and Its Application in the Analysis of Pharmaceuticals and Biological Fluids by María Cuartero, Mª Soledad García, Mustafa Salem Abuherba, Joaquín A. Ortuño

Subjects: Get full text

Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone by Roffeei, S.N., Reynolds, G.P., Zainal, N.Z., Said, M.A., Hatim, A., Aida, S.A., Mohamed, Z.

“…In this study, we aimed to determine whether risk polymorphisms in 12 candidate genes are associated with reduction in body mass index (BMI) of patients following switching of antipsychotics to aripiprazole or ziprasidone. MethodsWe recruited 115 schizophrenia patients with metabolic abnormalities and who have been on at least 1year treatment with other antipsychotics; they were then switched to either aripiprazole or ziprasidone. …”